IperionX Reports Lapse of 400,000 Performance Rights

Iperionx Limited ( (AU:IPX) ) has shared an update.

IperionX Limited has notified the market of a change in its issued capital following the lapse of certain performance rights. A total of 400,000 IPXAL performance rights ceased on April 23, 2026, after the specified conditions for converting these rights into securities were not satisfied or became incapable of being met.

The lapse of these conditional rights effectively reduces the pool of potential future equity that could have been created upon their vesting. This change may slightly affect future dilution expectations for existing shareholders, while signaling that the performance or vesting hurdles tied to these rights were not achieved within the required timeframe.

The most recent analyst rating on (AU:IPX) stock is a Buy with a A$9.90 price target. To see the full list of analyst forecasts on Iperionx Limited stock, see the AU:IPX Stock Forecast page.

More about Iperionx Limited

IperionX Limited is a listed company on the ASX under the ticker IPX, but the announcement provides no specific details about its industry, products, or services. As such, its precise market focus and operating sector cannot be determined from this document alone.

Average Trading Volume: 1,487,092

Technical Sentiment Signal: Sell

Current Market Cap: A$1.47B

Learn more about IPX stock on TipRanks’ Stock Analysis page.